Correlation between the prostaglandin D2/E2 ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma

Allergology International

Volumn 57, Issue 4, 2008, Pages 429-436

  Yoshimura, Tsuyoshi ^a   Yoshikawa, Mamoru ^a   Otori, Nobuyoshi ^a   Haruna, Shin Ichi ^b   Moriyama, Hiroshi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Aspirin intolerant asthma; Bronchial asthma; Chronic rhinosinusitis; Prostaglandin D2; Prostaglandin E2

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN D2; PROSTAGLANDIN E2;

ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; ASTHMA; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOSCOPIC SURGERY; ENDOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NOSE POLYP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RELAPSE; REMISSION; RHINOSINUSITIS; TISSUE LEVEL;

EID: 59549107363     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-08-545     Document Type: Article

References (43)

1. Borish L. Sinusitis and asthma: entering the realm of scientific study. J Allergy Clin Immunol 2002;109:606-8.
2. Kaliner MA, Osguthorpe JD, Fireman P et al. Sinusitis, bench to bedside. Current findings, future directions. J Allergy Clin Immunol 1997;99(6 Pt 3):S829-48.
3. Hamilos DL, Leung DYM, Wood R et al. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-α. Am J Respir Cell Mol Biol 1996;15:443-50.
4. Rachelefsky GS, Spector SL. Sinisitis and asthma. J Asthma 1990; 27:1-3.
5. Slavin RG. Complications of allergic rhinitis: implications for sinusitis and asthma. J Allergy Clin Immunol 1998;101 (2 Pt 2):S357-60.
6. Lamblin C, Tillie-Leblond I, Darras J et al. Sequential evaluation of pulmonary function and bronchial hyperresponsiveness in patients with nasal polyposis: a prospective study. Am J Respir Crit Care Med 1997;155:99-103.
7. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999; 28:717-22.
8. Drake-Lee AB. Medical treatment of nasal polyps. Rhinology 1994; 32:1-4.
9. Stammberger H. Surgical treatment of nasal polyps: past, present, and future. Allergy 1999;53:7-11.
10. Vennto SI, Ertamo LO, Hytonen ML et al. Nasal polyposis: clinical course during 20 years. Ann Allergy Asthma Immunol 2000; 85:209-14.
11. Samter M, Beers RF Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968; 68:975-83.
12. Stevenson DD. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol 1984;74:617-22.
13. Leff AR. Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Thorax 2000; 55(Suppl 2):S32-7.
14. Funk CD. Prostaglandins and leukotrienes, advances in eicosanoid biopsy. Science 2001;294:1871-5.
15. Borish L. The role of leukotrienes in upper and lower airway inflammation and the implications for treatments. Ann Allergy Asthma Immunol 2002;88:16-22.
16. Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR Jr. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodering. J Allergy Clin Immunol 2003;1111 (Suppl):S18-34.
17. Vignola AM. Effects of inhaled corticosteroids, leukotriene receptor antagonists, or both, plus long-acting beta2-agonists on asthma pathophysiology: a review of the evidence. Drugs 2003; 63:35-51.
18. Coleman RA, Sheldrick RL. Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors. Br J Pharmacol 1989;96:688-92.
19. 2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. J Allergy Clin Immunol 1994; 93:817-24.
20. 2 as a mediator of allergic asthma. Science 2000;287:2013-7.
21. 2 synthase transgenic mice. J Immunol 2002;168:443-9.
22. 2. Lancet 1995;345:436-8.
23. Kleeberger SR, Freed AN. Prostanoids. In: Busse W, Holgate S (eds). Asthma and Rhinitis. Blackwell Scientific Publications, 1995; 825-37.
24. 2 selectively enhanced IgE mediated production of IL-6 and GM-CSF by mast cells through an EP1/EP3 dependent mechanism. J Immunol 2000; 165:6545-52.
25. Phipps RP, Stein SH, Roper RL. A new view of prostaglandin E regulation of the immune response. Immunol Today 1991;12:349-52.
26. 2 after allergen inhalation in atopic asthmatics. Adv Prostaglandin Thromboxane Leukot Res 1991; 21A:433-6.
27. 2 into human airways during acute antigen challenge. N Engl J Med 1986;315:800-4.
28. Cipollone F, Fazia M, Lezzi A et al. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol 2004; 24:1259-65.
29. 2 on prostaglandin D synthase production in cultivated rat leptomeningeal cells. J Cereb Blood Flow Metab 2004;23:409-18.
30. 2 terminal synthases in chronic rhinosinusitis. Clin and Exp Allergy 2006;36:1028-38.
31. Nasser SM, Pfister R, Christie PE et al. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med 1996;153: 90-6.
32. 2 into human airways during acute antigen challenge. N Engl J Med 1986;315:800-4.
33. 2 in normal and asthmatic men. N Engl J Med 1984;311:209-13.
34. Baenkler HW, Schafer D, Hosemann W. Eicosanoids from biopsy of normal and polypous nasal mucosa. Rhinology 1996;34:166-70.
35. Kowalski ML, Pawliczak R, Wozniak J et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000;161:391-8.
36. Perez-Novo CA, Watelet JB, Claeys C, Van Cauwenberqe P, Bachert C. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005;115:1189-96.
37. Picado C, Fernandez-Morata JC, Juan M et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999;160:291-6.
38. Cao H, Xiao L, Park G et al. An improved LC-MS/MS method for the quantification of prostaglandins E (2) and D (2) production in biological fluids. Anal Biochem 2008; 372:41-51.
39. Schratl P, Royer JF, Kostenis E et al. The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking. J Immunol 2007;179:4792-9.
40. Jones CP, Paula Neto HA, Assreuy J, Vargaftig BB, Gaspar Elsas MI, Elsas PX. Prostaglandin E2 and dexamethasone regulate eosinophil differentiation and survival through a nitric oxide- and CD95-dependent pathway. Nitric Oxide 2004;11:184-93.
41. Gaspar Elsas MI, Joseph D, Lintomen L et al. Murine myeloid progenitor responses to GM-CSF and eosinophil precursor responses to IL-5 represent distinct targets for downmodulation by prostaglandin E (2). Br J Pharmacol 2000;130:1362-8.
42. 2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. J Allergy Clin Immunol 2003;111: 1041-8.
43. Kountakis SE, Arango P, Bradley D, Wade ZK, Borish L. Molecular and cellular staging for the severity of chronic rhinosinusitis. Laryngoscope 2004;114:1895-905.